405 related articles for article (PubMed ID: 30691396)
1. Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study.
Ohfuji S; Ito K; Inoue M; Ishibashi M; Kumashiro H; Hirota Y; Kayano E; Ota N
BMC Infect Dis; 2019 Jan; 19(1):95. PubMed ID: 30691396
[TBL] [Abstract][Full Text] [Related]
2. Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids.
Russell AF; Parrino J; Fisher CL; Spieler W; Stek JE; Coll KE; Su SC; Xu J; Li X; Schlienger K; Silber JL
Vaccine; 2015 Jun; 33(27):3129-34. PubMed ID: 25964168
[TBL] [Abstract][Full Text] [Related]
3. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
[TBL] [Abstract][Full Text] [Related]
4. A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL).
Popmihajlov Z; Pang L; Brown E; Joshi A; Su SC; Kaplan SS; Willis ED
Hum Vaccin Immunother; 2018; 14(12):2916-2920. PubMed ID: 30024827
[TBL] [Abstract][Full Text] [Related]
5. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.
Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA
Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682
[TBL] [Abstract][Full Text] [Related]
6. Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.
López-Fauqued M; Co-van der Mee M; Bastidas A; Beukelaers P; Dagnew AF; Fernandez Garcia JJ; Schuind A; Tavares-da-Silva F
Drug Saf; 2021 Jul; 44(7):811-823. PubMed ID: 34115324
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.
Miller G; Schaefer H; Yoder S; Miller R; Winokur P; Kotloff K; Klassen D; Wierzbicki M; Amegashie C; Edwards K
Transpl Infect Dis; 2018 Jun; 20(3):e12874. PubMed ID: 29512282
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.
Godeaux O; Kovac M; Shu D; Grupping K; Campora L; Douha M; Heineman TC; Lal H
Hum Vaccin Immunother; 2017 May; 13(5):1051-1058. PubMed ID: 28068212
[TBL] [Abstract][Full Text] [Related]
9. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008858. PubMed ID: 26937872
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial.
Hata A; Inoue F; Hamamoto Y; Yamasaki M; Fujikawa J; Kawahara H; Kawasaki Y; Honjo S; Koshiyama H; Moriishi E; Mori Y; Ohkubo T
Diabet Med; 2016 Aug; 33(8):1094-101. PubMed ID: 26605507
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults.
Choi WS; Choi JH; Choi JY; Eom JS; Kim SI; Pai H; Peck KR; Sohn JW; Cheong HJ
J Korean Med Sci; 2016 Jan; 31(1):13-7. PubMed ID: 26770032
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Gomes Silva BN; Torloni MR; Soares BG
Cochrane Database Syst Rev; 2012 Oct; 10():CD008858. PubMed ID: 23076951
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
[TBL] [Abstract][Full Text] [Related]
14. [Immunization of adults against varicella and herpes zoster].
Hanslik T; Blanchon T; Alvarez FP
Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
[TBL] [Abstract][Full Text] [Related]
15. A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su.
Strezova A; Godeaux O; Aggarwal N; Leroux-Roels G; Lopez-Fauqued M; Van Damme P; Vanden Abeele C; Vastiau I; Heineman TC; Lal H
Vaccine; 2017 Dec; 35(48 Pt B):6700-6706. PubMed ID: 29079101
[TBL] [Abstract][Full Text] [Related]
16. Varicella Virus Vaccination in the United States.
Shaw J; Gershon AA
Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study.
Lal H; Poder A; Campora L; Geeraerts B; Oostvogels L; Vanden Abeele C; Heineman TC
Vaccine; 2018 Jan; 36(1):148-154. PubMed ID: 29174683
[TBL] [Abstract][Full Text] [Related]
18. Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus.
Hata A; Inoue F; Yamasaki M; Fujikawa J; Kawasaki Y; Hamamoto Y; Honjo S; Moriishi E; Mori Y; Koshiyama H
J Infect; 2013 Sep; 67(3):215-9. PubMed ID: 23603250
[TBL] [Abstract][Full Text] [Related]
19. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C
Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
